Search SEPN
Septerna, Inc.
Nasdaq · CIK 1984086
Last close37.71
Daily change-0.34 (-0.89%)
10 Years gain+76.21%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
SEPN · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 1231
Fundamental
56.9Momentum
100.0Acceleration
100.0Confidence
64.0Annual Revenue3
Quarterly Revenue9
Annual CFO3
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth25.0 / 25
Quality14.1 / 25
Capital Efficiency0.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 7504.4935 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
High SBC · MEDIUMStock based compensation is high relative to revenue or FCF.
Key Metrics
Revenue Growth TTM6,820.79%OK
Revenue CAGR 3Yn/aINSUFFICIENT_HISTORY
Gross Margin100%OK
Operating Margin-75.45%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-30.92%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y2.51%OK
SBC / Revenue20.6%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $45.95M | $45.95M | -$68.30M | $110.19M | $109.67M | 100% | -148.63% | 238.67% | -179.97% | 44.26M |
| 2025 FY Dec 31, 2024 | $1.08M | $1.08M | -$80.82M | -$67.47M | -$69.57M | 100% | -7,518.42% | -6,471.91% | -415.29% | 9.89M |
| 2024 FY Dec 31, 2023 | $151,000.00 | $4.00M | $2.08M | -$38.72M | -$41.60M | 2,648.34% | 1,374.17% | -27,550.33% | n/a | 2.18M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $74.88M | sum latest 4 fiscal quarters Revenue | OK | 0001193125-26-342353, 0001193125-25-273375 |
| Revenue Growth TTM | 6,820.79% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001193125-26-342353, 0001193125-25-273375 |
| Revenue CAGR 3Y | n/a | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001193125-26-098507 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001193125-26-098507 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001193125-26-098507 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001193125-26-342353, 0001193125-25-273375 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 100% | Gross Profit / Revenue | OK | 0001193125-26-342353, 0001193125-25-273375 |
| Operating Margin | -75.45% | Operating Income / Revenue | OK | 0001193125-26-342353, 0001193125-25-273375 |
| ROIC | -30.92% | NOPAT / Average Invested Capital | OK | 0001193125-26-342353, 0001193125-25-273375 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001193125-26-342353 |
| Current Ratio | 4.99x | Current Assets / Current Liabilities | OK | derived |
| SBC / Revenue | 20.6% | SBC / Revenue | OK | 0001193125-26-342353, 0001193125-25-273375 |
| Revenue per Diluted Share | $1.66 | Revenue / Diluted Shares | OK | 0001193125-26-342353, 0001193125-25-273375 |